Gary L. Robertson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gary L. Robertson has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Reema L. Habiby
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
2 shared publications - Amar J. Majmundar
Division of Nephrology, Boston Children's Hospital, Boston, MA, United States
1 shared publication Andjela T. Drincic
1 shared publicationB.S. Chertow
1 shared publicationC. Siggaard
1 shared publication- Daniel Georges Bichet
Departments of Medicine and of Pharmacology and Physiology, University of Montreal, Montreal, Canada
1 shared publication
Latest Publications
- 9 February 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (6) , e2513-e2522
A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner
Context: Familial pituitary diabetes insipidus has been described only in an autosomal dominant or recessive mode of inheritance. Objective: This work aims to determine the cause of a novel form of familial diabetes insipidus (DI) that is controlled by desmopressin therapy but segregates in an X-linked recessive manner. Methods: Thirteen members from 3 generations of the kindred with familial DI were studied. Water intake, urine volume, urine osmolality, plasma osmolality, and plasma vasopressin were measured under basal conditions, during fluid deprivation, 3% saline infusion, and water loading. Magnetic resonance images of the posterior pituitary also were obtained. In affected males, the effects of desmopressin therapy and linkage of the DI to markers for chromosome Xq28 were determined. In addition, the genes encoding vasopressin, aquaporin-2, the AVPR2 receptor, and its flanking regions were sequenced. Results: This study showed that 4 males from 3 generations of the kindred have DI that is due to a deficiency of vasopressin, is corrected by standard doses of desmopressin, and segregates with markers for the AVPR2 gene in Xq28. However, no mutations were found in AVPR2 or its highly conserved flanking regions. Exome sequencing confirmed these findings and also revealed no deleterious variants in the provasopressin and aquaporin-2 genes. The 4 obligate female carriers osmo-regulated vasopressin in the low normal range. Conclusion: X-linked recessive transmission of DI can be due to a defect in either the secretion or the action of vasopressin. Other criteria are necessary to differentiate and manage the 2 disorders correctly.
- 9 February 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (6) , e2513-e2522
A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner
Context: Familial pituitary diabetes insipidus has been described only in an autosomal dominant or recessive mode of inheritance. Objective: This work aims to determine the cause of a novel form of familial diabetes insipidus (DI) that is controlled by desmopressin therapy but segregates in an X-linked recessive manner. Methods: Thirteen members from 3 generations of the kindred with familial DI were studied. Water intake, urine volume, urine osmolality, plasma osmolality, and plasma vasopressin were measured under basal conditions, during fluid deprivation, 3% saline infusion, and water loading. Magnetic resonance images of the posterior pituitary also were obtained. In affected males, the effects of desmopressin therapy and linkage of the DI to markers for chromosome Xq28 were determined. In addition, the genes encoding vasopressin, aquaporin-2, the AVPR2 receptor, and its flanking regions were sequenced. Results: This study showed that 4 males from 3 generations of the kindred have DI that is due to a deficiency of vasopressin, is corrected by standard doses of desmopressin, and segregates with markers for the AVPR2 gene in Xq28. However, no mutations were found in AVPR2 or its highly conserved flanking regions. Exome sequencing confirmed these findings and also revealed no deleterious variants in the provasopressin and aquaporin-2 genes. The 4 obligate female carriers osmo-regulated vasopressin in the low normal range. Conclusion: X-linked recessive transmission of DI can be due to a defect in either the secretion or the action of vasopressin. Other criteria are necessary to differentiate and manage the 2 disorders correctly.
- 1 November 2018
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 379 (18) , 1784-1786
Copeptin in the Diagnosis of Diabetes Insipidus
In their study of the value of copeptin for diagnosing diabetes insipidus, Fenske et al. (Aug. 2 issue)1 overlook two possible methodologic flaws. First, some of their patients appear to have had an element of a solute diuresis. For example, among patients with primary polydipsia, the product of the baseline median urine osmolality (408 mOsm per kilogram) and a urine volume of 4 liters per day or more indicates that in some patients the daily urine solute load was more than 1600 mOsm, which greatly exceeds the normal value (approximately 10 mOsm per kilogram per day).2,3 Second, the water-deprivation test was incomplete. The goal is to raise the serum sodium and endogenous vasopressin levels sufficiently to induce maximal urine concentration, as shown by stability of the urine osmolality.4,5 This critical step was omitted. Therefore, we cannot know whether the stimulus was adequate and whether restricting water longer would have changed the results. That the serum sodium levels were notably higher after the administration of hypertonic saline than after water deprivation suggests that it might have. Thus, the authors’ conclusion that measurement of hypertonic saline–stimulated copeptin is superior to water-deprivation testing seems premature.
- 1 November 2018
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 379 (18) , 1784-1786
Copeptin in the Diagnosis of Diabetes Insipidus
In their study of the value of copeptin for diagnosing diabetes insipidus, Fenske et al. (Aug. 2 issue)1 overlook two possible methodologic flaws. First, some of their patients appear to have had an element of a solute diuresis. For example, among patients with primary polydipsia, the product of the baseline median urine osmolality (408 mOsm per kilogram) and a urine volume of 4 liters per day or more indicates that in some patients the daily urine solute load was more than 1600 mOsm, which greatly exceeds the normal value (approximately 10 mOsm per kilogram per day).2,3 Second, the water-deprivation test was incomplete. The goal is to raise the serum sodium and endogenous vasopressin levels sufficiently to induce maximal urine concentration, as shown by stability of the urine osmolality.4,5 This critical step was omitted. Therefore, we cannot know whether the stimulus was adequate and whether restricting water longer would have changed the results. That the serum sodium levels were notably higher after the administration of hypertonic saline than after water deprivation suggests that it might have. Thus, the authors’ conclusion that measurement of hypertonic saline–stimulated copeptin is superior to water-deprivation testing seems premature.
- 1 January 2001
- Published by Walter de Gruyter GmbH in International Journal on Disability and Human Development
- Vol. 2 (2) , 105-114
A Novel AVP-Neurophysin Gene Mutation in Familial Neurohypophyseal Diabetes Insipidus Presenting with Nocturnal Enuresis
Article A Novel AVP-Neurophysin Gene Mutation in Familial Neurohypophyseal Diabetes Insipidus Presenting with Nocturnal Enuresis was published on April 1, 2001 in the journal International Journal on Disability and Human Development (volume 2, issue 2).
- 1 January 2001
- Published by Walter de Gruyter GmbH in International Journal on Disability and Human Development
- Vol. 2 (2) , 105-114
A Novel AVP-Neurophysin Gene Mutation in Familial Neurohypophyseal Diabetes Insipidus Presenting with Nocturnal Enuresis
Article A Novel AVP-Neurophysin Gene Mutation in Familial Neurohypophyseal Diabetes Insipidus Presenting with Nocturnal Enuresis was published on April 1, 2001 in the journal International Journal on Disability and Human Development (volume 2, issue 2).
- Open Access
- 1 April 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (4) , 67
A Novel X-linked Form of Familial Neurohypophyseal Diabetes Insipidus. • 386
- 1 April 1997
- Published by Springer Nature in Pediatric Research
- Vol. 41 (4) , 67
Open AccessA Novel X-linked Form of Familial Neurohypophyseal Diabetes Insipidus. • 386